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Biallelic mutation of Protocadherin-21 (PCDH21) causes retinal
degeneration in humans
Robert H. Henderson,1,2 Zheng Li,2 Mai M. Abd El Aziz,2 Donna S. Mackay,2 Mohammad A. Eljinini,3
Marwan Zeidan,4 Anthony T. Moore,1,2 Shomi S. Bhattacharya,2 Andrew R. Webster1,2
1Moorfields Eye Hospital, London, UK; 2Institute of Ophthalmology, University College of London, London, UK; 3Alisra Private
University, Amman, Jordan; 4Jordan Hospital, Amman, Jordan
Purpose: To describe the clinical findings and mutations in affected members of two families with an autosomal recessive
retinal dystrophy associated with mutations in the protocadherin-21 (PCDH21) gene.
Methods: A full genome scan of members of two consanguineous families segregating an autosomal recessive retinal
dystrophy was performed and regions identical by descent identified.  Positional candidate  genes were identified and
sequenced. All patients had a detailed ophthalmic examination, including electroretinography and retinal imaging.
Results: Affected members of both families showed identical homozygosity for an overlapping region of chromosome
10q. Sequencing of a candidate gene, PCDH21, showed two separate homozygous single-base deletions, c.337delG
(p.G113AfsX1) and c.1459delG (p.G487GfsX20), which were not detected in 282 control chromosomes. Affected
members of the two families first reported nyctalopia in late teenage years and retained good central vision until their late
30s. No color vision was detected in any proband. The fundus appearance included the later development of characteristic
circular patches of pigment epithelial atrophy at the macula and in the peripheral retina.
Conclusions: Biallelic mutations in the photoreceptor-specific gene PCDH21 cause recessive retinal degeneration in
humans.
Retinitis pigmentosa (RP) is a genetically determined
disorder in which there is progressive dysfunction and
degeneration of the rod and cone photoreceptors. Inheritance
may be autosomal dominant, autosomal recessive, and X-
linked recessive, and even among these genetic subtypes there
is considerable genetic heterogeneity. Most progress has been
made in identifying genes causing autosomal dominant and
X-linked disease (RetNet). In recessive RP, current genes
account for only 50% of families in which retinal disease is
the only manifestation [1].
As part of a larger study investigating the genetic causes
of RP and early onset retinal dystrophies, we used
autozygosity mapping in two consanguineous families with
autosomal recessive Retinitis Pigmentosa (arRP)to identify a
common autozygous region on chromosome 10q. We
subsequently identified null mutations in protocadherin-21
(PCDH21), a photoreceptor-specific gene [2,3], as the cause
of the retinal disease in these families.
METHODS
Recruitment of families: Two families with an adult onset
form of arRP were ascertained at our institution and pedigrees
constructed (Figure 1). The first (family 1) was a two-
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generation consanguineous family of Middle-Eastern descent
with 4 affected (2 male and 2 female) and two unaffected
siblings. The affected individuals ranged in age from 32 to 42
years. The second (family 2) was a consanguineous family of
South Asian descent with one affected male individual and
three unaffected siblings. Informed consent was obtained
from all study participants, and the study conformed to the
tenets of the Declaration of Helsinki. Two 10 ml EDTA tubes
of peripheral venous blood were drawn from all available
family members, including both affected and unaffected
individuals, and samples were frozen. DNA was extracted
using the Nucleon™ BACC-2 genomic DNA kit (GE
Healthcare Life Sciences, Buckinghamshire, UK). Following
cell lysis, deproteinization was performed using sodium
perchlorate. DNA extraction was achieved with chloroform
and Nucleon™ resin before DNA recovery and washing.
DNA analysis: Genome-wide linkage scans were performed
to identify regions of autozygosity (where both alleles are
identical by descent and are copies of a common ancestral
gene). DNA samples from all affected family members were
genotyped using the Affymetrix human GeneChip® Mapping
Array (version Xba142 2.0) for family 1 and the GeneChip®
Human Mapping 100 K set array for family 2 (Affymetrix,
Santa Clara, CA). The detailed methodology for genotyping
using the GeneChip® array has been previously described
[4]. Briefly, 250 ng of genomic DNA was digested with XbaI
(New England Biolabs, Ipswich, MA) for 2 h at 37 °C, ligated
with XbaI adaptors using T4 DNA ligase (New England
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Biolabs). The ligation reaction was diluted in 1:4 (vol/vol)
with molecular grade water (Sigma-Aldrich, St. Louis, MO)
to 100 µl. Ten µl of the diluted ligation mix was used to setup
selection by PCR (Fragment Selection by PCR) in triplicates.
The pooled PCR products were purified using QIAGEN
MinElute 96 UF plate (Qiagen, Duesseldorf, Germany). The
concentration of PCR products was quantified using ND-1000
Nanodrop spectrometry (Thermo Fisher Scientific, Waltham,
MA). Purified PCR product (90 ng) was fragmented with 0.25
units DNaseI ('Fragmentation Reagent'; Affymetrix), labeled
with 'Labeling Regent' (Affymetrix). The labeling reaction
(70 µl) was mixed with 190 μl hybridization reagent and
denatured at 99 °C for 10 min (all as detailed in the Affymetrix
GeneChip Mapping 100K Assay Manual). Finally the
denatured hybridization mixture was injected into Affymetrix
Human Mapping XbaI chips and incubated at 48 °C for 16 h,
followed by automatic washing and staining in a Fluidics
Station 450, and scanned by using the GeneChip® Scanner
3000 7G (Affymetrix). Primers for direct sequencing were as
described by Bolz et al. [5]. PCR amplification was performed
using a 20-µl reaction mix, including Abgene Reddymix with
or without dye (AB795, AB793; Abgene, Epsom, UK). Ten
microliters of Reddymix was combined with 5 µl of deionized
water, 2 µl (10 pmol) of forward and reverse primer, and 1 µl
(50–100 ng) of genomic DNA. All exons were optimized and
amplified at 55 °C. DNA fragments were purified using
Montage PCR cleanup plates, according to the standard
protocol (Millipore, Watford, UK). PCR cleanup (purple
plates) was performed using 15 μl of PCR product made up
to 100 μl with deionized water (ddH2O) and transferred to the
purple plates. Ten min of vacuum was applied to the plates
until the wells were empty. Twenty five μl of ddH2O was
added to each well and a further 3 min vacuum was applied.
Twenty μl of ddH2O was added to each well; the plate covered
and vortexed at 1,000 rpm for 10 min. The remaining contents
of each well (clean PCR product) was then transferred for
storage. The Big Dye terminator cycle sequencing reaction
was then performed using a 10-µl reaction mixture containing
0.5 µl of BigDye v3.1 Applied Biosystems™ (ABI Ltd,
Warrington, Cheshire. UK), 2 µl of PCR product, 1.5 µl of 5
picomolar (pM) forward or reverse primer, 3.5 µl of ddH2O,
and 2.5 µl of sequencing buffer (ABI Ltd) containing 5x Tris-
HCl and MgCl2. The sequencing reaction mixture was purified
using the Montage sequence cleanup plate (Millipore,
Watford, UK): 25 μl of injection solution (Millipore,) were
added to each well, and the total 35 μl was transferred to the
blue plate and vacuumed for 3 min. A further 25 μl of injection
solution was added to each well and vacuumed again for 4
min. Twenty five μl of injection solution was again added to
each well, the plate covered and vortexed for 10 min. The
remaining volume was transferred to the sequencing plate and
run on the ABI 3700 sequencer. The DNA sequence was
analyzed using DNAStar® Inc. (Madison, WI). To check
segregation of the mutant alleles with disease, restriction
digests were performed. Family 1 was investigated using
HaeIII enzyme (Figure 2; New England Biolabs Ltd, NEB,
Hitchin, Herts, UK), while in family 2 a digest using an E.
coli strain that carries the BglI gene from Bacillus globigii
(BglI [NEB]) was performed. One unit (0.2 μl) of enzyme was
combined with 2 μl of 1x NEBuffer 3 (NEB, Herts, UK),
10 μl of PCR product and brought to a 20 μl reaction volume
with deionized H2O (ddH2O) and digested for 16 h at 37 °C.
Heat inactivation was performed at 80 °C for 20 min and the
product run out on a 5% agarose gel.
Clinical examination: Affected individuals underwent a full
clinical examination, including Logarithm of the Minimum
Angle of Resolution (LogMAR) visual acuity, color vision
testing using the Ishihara plates, refraction, slit-lamp
biomicroscopy, Goldmann visual field testing, and color
fundus photography. A subset of patients underwent
Figure 1. The pedigrees of the two
families that took part in the study
(denoted family 1 and 2 in the text) are
displayed. Open and closed symbols
denote unaffected and affected
individuals, respectively. Deceased
family members are denoted by
diagonal lines; arrows indicate the
probands in each family. A horizontal
double line between parents indicates
consanguinity. Panel A is a pedigree
drawing of family 1, a first cousin
consanguineous middle-eastern family,
with four affected siblings. Panel B
shows the nuclear family who took part
in the study, and is part of a larger
consanguineous pedigree not displayed
or available for the study; the parents
illustrated are first cousins.
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electroretinography using International Society for Clinical
Electrophysiology of Vision (ISCEV) protocols [6,7].
RESULTS
In family I, analysis of the data from the Affymetrix gene chip
array revealed a region of 47 contiguous homozygous single
nucleotide polymorphisms (SNPs) on chromosome 10q23.1–
23.3 spanning an interval of 10 cM in all four affected
individuals. The parents and two unaffected siblings were
heterozygous for these SNPs. This was the only significant
region where affected individuals were homozygous and
unaffected family members were not. The region contained
approximately 45 genes of which four, PCDH21 (OMIM
609502); LRRC21 (leucine-rich repeat-containing protein 21
precursor, retina-specific protein photoreceptor-associated
LRR superfamily [8]); RGR (retinal pigment epithelium
[RPE]-retinal G protein-coupled receptor - OMIM 600342),
Figure 2. Electropherograms of the
mutations detected in Protocadherin-21
(PCDH21). Panel A illustrates the index
c.338delG mutation in family 1; the
wild-type (WT) sequence is displayed
on the top row. The middle row shows
the proband in family 1 (IV-2) with a
homozygous (HM) c.338delG change,
illustrated with a dash for the missing
nucleotide when aligned with the
wildtype sequence. The bottom row
displays an unaffected parent of family
1 (III-3) with the c.338delG change in
the heterozygous state (Het): the latter
section of the heterozygous
electropherogram shows two
superimposed sequences due to the
synchronous addition of nucleotides due
to two distinct DNA templates derived
from the wild type and the shorter
mutant alleles of the heterozygote. Panel
B illustrates the second mutation that
was identified in PCDH21, in family 2.
The top row displays the control
individual with the wildtype (WT)
allele; while the bottom row displays the
affected proband (II-1) with a
homozygous (HM) c.1463delG variant.
Figure 3. Co-segregation study of
members of family 1 using the HaeIII
restriction enzyme. Lane 1 is an
undigested PCR product (286 bp). Lane
2 is a completely digested PCR product
representing the wild-type allele (two
products 197 and 56 bp). Affected
individuals (lanes 4, 8, 9, and 10) show
the homozygous mutant allele (one
product 253 bp). Unaffected
individuals, carriers (lanes 3, 5, 6, and
7) display the mutant allele in a
heterozygous state (two products 253
and 197 bp). M represents the
ϕX174RF DNA HaeIII marker.
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and OPN4 (melanopsin - OMIM 606665), were highly
expressed in the retina relative to other human tissues
(NCBI).
Direct sequencing of the coding regions and intron–exon
boundaries of LRRC21 and RGR showed no variants in
affected individuals. Sequencing of the 17 coding exons of
PCDH21 showed a homozygous single base deletion within
exon 4, c.338delG p.G113AfsX1 (Figure 2A). The mutation
segregated as a recessive allele in the family (Figure 3) and
was not detected in 292 control chromosomes (86 UK blood
donors, European Collection of Cell Cultures (ECACC) and
60 ethnically matched control individuals). In addition, the
specific change was not found in a panel of DNA from 192
arRP and 96 Leber congenital amaurosis (LCA) patients
recruited from Moorfields Eye Hospital (London, UK).
In family 2, the largest region of autozygosity, which
contained 195 contiguous homozygous SNPs, was on
chromosome 10q. Direct sequencing of PCDH21 revealed a
homozygous single-base deletion in exon 13, c.1459delG,
p.G487GfsX20 (Figure 2B). This is predicted to lead to
truncation of the protein through a premature stop codon, 19
codons downstream of the deletion. This deletion segregated
as a recessive allele in family 2 and was not found in 292
control chromosomes or in our LCA and arRP panel. Both
deletions reside within the cadherin domains of the protein
and occur at amino-acid positions that are highly conserved
across species (Figure 4A-D).
The clinical history and phenotype in affected members
of both families was similar. In family 1, nyctalopia was first
reported in late teenage years, and photophobia occurred in
the mid-twenties. The visual acuity was 0.1 (LogMAR) in the
early 30s, deteriorating to “hand movements” by the early 40s.
All affected family members had a severe color vision defect,
and all had a low myopic refractive error. Fundus examination
revealed vessel attenuation, diffuse retinal pigment epithelial
changes, and sparse bone spicule pigment migration in the
retinal periphery in the younger patients. With disease
progression, there was dense pigment migration and atrophy
both at the macula and in the periphery (Figure 5A–D).
Electroretinography (ERG) in the three oldest affected
individuals (age 42, 40, 34) showed both rod and cone
responses; the ERG in the youngest affected family member,
age 32 years (IV6), showed a cone–rod pattern of disease.
Only one affected individual in family 2 was available for
examination. He had onset of symptomatic night blindness at
18 years of age. When examined at 30, his visual acuity was
Figure 4. These are illustrations of both
the exon structure and a schematic of the
Protocadherin-21 (PCDH21) protein
with indications of the location of the
two deletions. Sequence alignments
demonstrate the conservation of both
amino-acid positions across several
species. Panel A: PCDH21 exon
structure as derived from ensembl: the
exons are colored according to domain
structure, and, as illustrated in Panel B,
with asterisks to denote the location of
the novel deletions. Panel B is a
schematic of the cellular domain
structure derived from UniProt (created
using Adobe Illustrator-Adobe Systems
Inc.) with the protein numbers
corresponding to each of the structural
domains. Panel C is an sequence
alignment created using PipeAlign for
PCDH21 mutation p.G113fsX1, that
was identified in family 1, and shows
that there is a high level of conservation
at this amino acid position-except for
species Danio rerio. Panel D is a further
alignment around the site of the
PCDH21 deletion p.G487fsX20,
identified in family 2, demonstrating a
high level of conservation at this amino
acid position and therefore providing
evidence of the likely deleterious effect
of this variant.
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Figure 5. Color fundus composite
photographs of affected individuals
from families 1 and 2 and Goldmann
visual fields from the proband in family
2. Panel A shows a fundus composite of
the right eye from 34-year-old male (IV:
6) from family 1; his visual acuity (VA)
was 0.1 LogMAR with an
electroretinogram (ERG) that was
consistent with a “mild cone–rod
dystrophy.” The image shows evidence
of vessel attenuation and early
peripheral retinal atrophy with few bone
spicules. Panel B shows a fundus
composite of the right eye in 36-year-old
female (IV:5) from family 1 whose VA
was 0.3 LogMAR, and who had absent
color vision; her ERG was consistent
with a diagnosis of retinitis pigmentosa.
The fundus image shows macular
depigmentation, dense peripheral bone
spicules, and vessel attenuation. Panel
C displays the color fundus composite
from the left eye of 42-year-old male
(IV:3) from family 1. His VA was 1.3
LogMAR, and the image displays
circular patches of RPE atrophy both at
the macula and in the periphery with
associated peripheral pigment
migration. His ERG was described as
consisted with “advanced RP.” Panel
D shows a color fundus composite from
the right eye of 44-year-old female (IV:
2) from family 1; Her visual acuity was
limited to Counting Fingers (CF) and the
view of the posterior pole is obscured by
dense asteroid hyalosis as seen; there is
peripheral bone spicule pigmentation
and circular pigment epithelial atrophy
was observed in the far periphery. Panel
E shows the left eye color fundus
composite of 46-year-old male (II:1)
from family 2. His VA was recorded as
Hand Movements (HM) at his most
recent examination. No color vision was
ever detected; the fundus image shows
an atrophic retina, with vessel
attenuation, RPE atrophy around the
disc, at the macula and in the periphery,
and associated peripheral pigment
migration. His ERG when tested at age
32 years was undetectable. Panel F
displays the Goldmann visual fields for
patient II:1 with the V4e isopter in green
and III4e in red: there are peripheral
islands of residual vision and no
response centrally to the largest and
brightest target (V4e) in the right eye
and small areas of response in the left
eye.
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0.2 LogMAR in each eye, but this had declined to 1.5
LogMAR in each eye at the age of 44 years and hand
movements (HM) by the age of 46 years. His refraction
measured −5 diopters spherical equivalent. Color vision was
very abnormal at his initial examination. His fundus findings
were of early RPE depigmentation at the macula at age 32
years. Later there were circular patches of pigment epithelial
atrophy both at the macula and in the periphery associated
with pigment migration and vessel attenuation (Figure 5E).
Goldmann visual field testing at 46 years of age revealed
residual peripheral islands of vision to the largest and brightest
targets (V4e and III4e; see Figure 5F). The ERG at age 34
years revealed no detectable rod or cone responses in either
eye.
DISCUSSION
PCDH21 is photoreceptor-specific cadherin involved in the
assembly of outer segment discs [2]. The protein is present at
the base of the developing outer segment and co-localizes with
Prominin 1 – a gene encoding a pentaspan transmembrane
glycoprotein (PROM1). Both proteins are involved in disc
morphogenesis [9]. Mutations in PROM1 have been
implicated in autosomal dominant cone rod dystrophy and
arRP [10,11]. Yang et al. [9] postulated that PCDH21,
PROM1, and cytoskeletal actin are responsible for the
formation of nascent discs at the base of the outer segment
model whereby new disc membranes form by an evagination
of the ciliary plasma membrane followed by rim growth. In
contrast to the pcdh2 −/− mice generated by Rattner et al. [2]
in which the outer segments were shortened, fragmented, and
degenerate, the mutant prom1 (R373C) transgenic mice have
stacks of disc membranes that were of excessive size and
aligned perpendicular to normal disc orientation.
PCDH21 is a good candidate for human inherited retinal
degenerations, and Bolz et al. [5] screened a large number of
arRP, LCA, and Usher syndrome type 1 patients; three
heterozygous variants were described but none that were
shown to be definitely disease associated. Our study provides
evidence that PCDH21 is a rare cause of nonsyndromic RP.
The retinal phenotype is consistent in the two families
with night vision loss in the late teenage years but relatively
well preserved central vision until the late 30s. In the early 40s
vision deteriorates markedly. There are characteristic circular
patches of pigment epithelial atrophy both at the macula and
in the periphery appearing late in the disease process. This
atrophy of the RPE and inner choroid occurring together with
photoreceptor dysfunction suggest that phagocytosis of
abnormal outer segments of the mutant retina might have a
toxic effect on the RPE. All affected individuals examined had
severe color vision defects, and ERGs performed at the
referring institution (family 1) and at our institution (family
2) revealed severe cone and rod degeneration; the youngest
affected individual had a cone–rod pattern of disease,
suggesting that the earliest manifestation of mutations in
PCDH21is a cone–rod dystrophy.
In summary, we have identified two consanguineous
families who have separate, novel, homozygous, frame-
shifting deletions that result in stop mutations that would be
expected to abrogate protein function and cause nonsense-
mediated decay [12] of the transcribed RNA. The phenotype
is of a retinal dystrophy that begins in late teenage years with
nyctalopia and visual field defects and by the fourth decade
results in significantly impaired central vision.
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